"North Suffolk Neurology offers specialized neurological treatment options for both adults and children including Concussions, Headaches, Pain Management, Seizure Disorders, Neuromuscular conditions, Multiple Sclerosis, and Sleep Medicine."

During the past decade, North Suffolk Neurology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Suffolk Neurology" #1 sponsor was "Pfizer" with 5 trials, followed by "Annovis Bio Inc." with 1 trials sponsored, "Ipsen" with 1 trials sponsored, "Satsuma Pharmaceuticals, Inc." with 1 trials sponsored and "Tian Medical Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Suffolk Neurology" #1 collaborator was "Clinvest Research, LLC" with 1 trials as a collaborator, "Ki Health Partners. LLC" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "TAMM Net, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "North Suffolk Neurology" are "Migraine" (2 trials), "Acute Treatment of Migraine" (1 trials), "Alzheimer Disease" (1 trials), "Headache, Migraine" (1 trials) and "Migraine With Aura" (1 trials). Many other conditions were trialed in "North Suffolk Neurology" in a lesser frequency.

Most popular intervention types in "North Suffolk Neurology" are "Drug" (7 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Rimegepant" (2 trials), "AboBoNT-A" (1 trials), "BHV-3500 (zavegepant)" (1 trials) and "Dihydroergotamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Suffolk Neurology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "North Suffolk Neurology". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in North Suffolk Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in North Suffolk Neurology, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".